Zweig Advisers’s Biogen BIIB Stock Holding History

Zweig Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,900	Closed	-$8.04M	–	77
2016 Q1	$8.04M	Hold	30,900	–	–	1.35%	48
2015 Q4	$9.47M	Hold	30,900	–	–	1.57%	43
2015 Q3	$9.02M	Buy	30,900 +3,600	+13%	+$1.19M	1.56%	46
2015 Q2	$11M	Hold	27,300	–	–	1.67%	36
2015 Q1	$11.5M	Sell	27,300 -3,500	-11%	-$1.38M	1.65%	41
2014 Q4	$10.5M	Hold	30,800	–	–	1.43%	48
2014 Q3	$10.2M	Sell	30,800 -1,500	-5%	-$495K	1.47%	46
2014 Q2	$10.2M	Buy	32,300 +2,900	+10%	+$873K	1.42%	47
2014 Q1	$8.99M	Sell	29,400 -4,600	-14%	-$1.46M	1.27%	48
2013 Q4	$9.51M	Sell	34,000 -6,300	-16%	-$1.63M	1.31%	49
2013 Q3	$9.7M	Buy	40,300 +1,500	+4%	+$336K	1.44%	41
2013 Q2	$8.35M	Buy	+38,800	New	+$8.29M	1.29%	45

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Zweig Advisers's BIIB Position: Q2 2016 in Review

Zweig Advisers sold out of Biogen (BIIB) in Q2 2016, closing a stake of 30,900 shares — an estimated $8.04M sold.

Zweig Advisers first reported a position in BIIB in Q2 2013 and held it in 12 quarters. The position peaked at $11.5M in Q1 2015. 965 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

Zweig Advisers reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
Zweig Advisers sold 30,900 Biogen shares in Q2 2016, an estimated $8.04M.
Zweig Advisers first reported a position in Biogen in Q2 2013 and held it in 12 quarters.
Zweig Advisers's Biogen position peaked at $11.5M in Q1 2015.
965 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Zweig Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.